Compounds > artesunic acid
Page last updated: 2024-08-26

artesunic acid and Angiogenesis, Pathologic

artesunic acid has been researched along with Angiogenesis, Pathologic in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (33.33)29.6817
2010's6 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu, Q; Wang, K; Zhao, C1
Das, P; Kumar, VL; Verma, S1
Feng, X; Fu, Y; Gao, Q; Hu, J; Li, C; Li, Y; Lin, L; Lin, X; Liu, B; Lu, L; Qian, X; Shao, W; Wen, X; Yang, Y; Zheng, H; Zheng, Q; Zhuo, Y1
Bogaerts, E; Colle, I; Descamps, B; Devisscher, L; Geerts, A; Janssens, S; Lambrecht, BN; Laukens, D; Libbrecht, L; Paridaens, A; Van Steenkiste, C; Van Vlierberghe, H; Vandewynckel, YP; Vanhove, C; Verhelst, X1
Choi, HY; Jeon, SS; Jeong, BC; Jeong, DE; Joo, KM; Lee, HW; Lee, SJ; Lim, JE; Lim, S; Nam, DH; Song, HJ1
Gao, Q; He, H; Huang, Z; Li, Y; Lin, L; Qian, X; Yang, W; Yuan, Y; Zheng, Q; Zong, Y1
HE, RR; ZHOU, HJ1
Chen, HH; Fang, X; Zhou, HJ1
Huan-huan, C; Li-Li, Y; Shang-Bin, L1

Reviews

1 review(s) available for artesunic acid and Angiogenesis, Pathologic

ArticleYear
Progress in research on the anti-tumor effect of artesunate.
    Chinese journal of integrative medicine, 2008, Volume: 14, Issue:4

    Topics: Amebicides; Animals; Antimalarials; Antineoplastic Agents; Apoptosis; Artemisinins; Artesunate; Free Radicals; Humans; Immunosuppression Therapy; Iron; Neovascularization, Pathologic; Tumor Cells, Cultured

2008

Other Studies

8 other study(ies) available for artesunic acid and Angiogenesis, Pathologic

ArticleYear
Artesunate attenuates ACLT-induced osteoarthritis by suppressing osteoclastogenesis and aberrant angiogenesis.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2017, Volume: 96

    Topics: Animals; Anterior Cruciate Ligament Injuries; Artemisinins; Artesunate; Male; Neovascularization, Pathologic; Osteoarthritis; Osteogenesis; Random Allocation; Rats; Rats, Wistar

2017
Chemoprevention by artesunate in a preclinical model of colorectal cancer involves down regulation of β-catenin, suppression of angiogenesis, cellular proliferation and induction of apoptosis.
    Chemico-biological interactions, 2017, Dec-25, Volume: 278

    Topics: 1,2-Dimethylhydrazine; Aberrant Crypt Foci; Animals; Apoptosis; Artemisinins; Artesunate; Aspirin; bcl-2-Associated X Protein; beta Catenin; Cell Proliferation; Colorectal Neoplasms; DNA Fragmentation; Down-Regulation; Male; Matrix Metalloproteinase 9; Neovascularization, Pathologic; Proliferating Cell Nuclear Antigen; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar; Vascular Endothelial Growth Factor A

2017
A Pilot Clinical Study of Intravitreal Injection of Artesunate for Ocular Neovascularization.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2019, Volume: 35, Issue:5

    Topics: Adolescent; Adult; Aged; Artesunate; Female; Humans; Intravitreal Injections; Male; Middle Aged; Neovascularization, Pathologic; Ophthalmic Solutions; Pilot Projects; Retinal Neovascularization; Young Adult

2019
Therapeutic effects of artesunate in hepatocellular carcinoma: repurposing an ancient antimalarial agent.
    European journal of gastroenterology & hepatology, 2014, Volume: 26, Issue:8

    Topics: Animals; Antineoplastic Agents; Artemisinins; Artesunate; Carcinoma, Hepatocellular; Cell Death; Dose-Response Relationship, Drug; Drug Repositioning; Drug Resistance, Neoplasm; Drug Therapy, Combination; Humans; Liver Neoplasms; Liver Neoplasms, Experimental; Male; Mice; Neovascularization, Pathologic; Niacinamide; Phenylurea Compounds; Sorafenib; Treatment Outcome; Tumor Cells, Cultured; Unfolded Protein Response

2014
Repurposing the anti-malarial drug artesunate as a novel therapeutic agent for metastatic renal cell carcinoma due to its attenuation of tumor growth, metastasis, and angiogenesis.
    Oncotarget, 2015, 10-20, Volume: 6, Issue:32

    Topics: Animals; Antigens, CD; Antimalarials; Antineoplastic Agents; Artemisinins; Artesunate; Carcinoma, Renal Cell; Cell Death; Cell Line, Tumor; Cell Proliferation; Female; Human Umbilical Vein Endothelial Cells; Humans; Kidney Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Neoplasm Metastasis; Neovascularization, Pathologic; Prognosis; Reactive Oxygen Species; Receptors, Transferrin; Xenograft Model Antitumor Assays

2015
Small Molecular-Sized Artesunate Attenuates Ocular Neovascularization via VEGFR2, PKCα, and PDGFR Targets.
    Scientific reports, 2016, 08-02, Volume: 6

    Topics: Animals; Artemisinins; Artesunate; Macaca fascicularis; Macular Edema; Male; Neovascularization, Pathologic; Pilot Projects; Protein Kinase C-alpha; Rabbits; Receptors, Platelet-Derived Growth Factor; Retinal Neovascularization; Vascular Endothelial Growth Factor Receptor-2

2016
Inhibition of human cancer cell line growth and human umbilical vein endothelial cell angiogenesis by artemisinin derivatives in vitro.
    Pharmacological research, 2003, Volume: 48, Issue:3

    Topics: Angiogenesis Inhibitors; Artemisinins; Artesunate; Cell Culture Techniques; Cell Line, Tumor; Dose-Response Relationship, Drug; Endothelium, Vascular; Growth Inhibitors; Humans; Neovascularization, Pathologic; Sesquiterpenes; Umbilical Veins

2003
Artesunate reduces chicken chorioallantoic membrane neovascularisation and exhibits antiangiogenic and apoptotic activity on human microvascular dermal endothelial cell.
    Cancer letters, 2004, Aug-10, Volume: 211, Issue:2

    Topics: Allantois; Angiogenesis Inhibitors; Animals; Antimalarials; Apoptosis; Artemisia; Artemisinins; Artesunate; Cell Differentiation; Cell Division; Chick Embryo; Chorion; DNA Damage; Dose-Response Relationship, Drug; Neovascularization, Pathologic; Receptors, Vascular Endothelial Growth Factor; Sesquiterpenes; Vascular Endothelial Growth Factor A

2004